ArticleEvidence-based complementary and alternative medicine : eCAM2019

Corrigendum to "Toll-Like Receptor 4-Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Shikonin Treatment of CIA by Regulating Treg/Th17 Expression".

Qiaomei Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.